The Cooper Companies, Inc. COO CooperVision — Research and development expense
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by The Cooper Companies, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.
The official record: The Cooper Companies, Inc.’s 10-Q, filed June 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about The Cooper Companies, Inc.'s coopervision — research and development expense.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is The Cooper Companies, Inc.'s coopervision — research and development expense?
- The Cooper Companies, Inc. (COO) reported coopervision — research and development expense of $22.1M in Q1 2026.
- How has The Cooper Companies, Inc.'s coopervision — research and development expense changed year-over-year?
- The Cooper Companies, Inc.'s coopervision — research and development expense decreased by 13.7% year-over-year, from $25.6M to $22.1M.
- What does coopervision — research and development expense mean?
- The amount spent on developing new products and improving existing lens technologies.
- How do you interpret coopervision — research and development expense?
- Higher spending indicates a commitment to future product pipelines, while lower spending may signal a focus on short-term profitability over innovation.
- How does coopervision — research and development expense compare across companies?
- Standard R&D expense metric for medical device and healthcare technology companies.